- HOME
- SMB·BIO
-
LX Hausys names 6 new directors in 2027 executive reshuffle
New director appointments expand from 1 last year to 6 this year Talent tapped across windows, functional materials and automotive materials units Company eyes new growth engines and future leadership development LX Hausys announced Wednesday that it conducted its regular 2027 executive reshuffle, appointing six new directors. The newly appointed directors are Lee Myung-hoon as chief safety officer, Kim Jeong-rak as chief human resources officer, Cho Young-hwan as head of windows sales, Yoon Seok-ho as head of functional materials business, Kim Tae-su as head of automotive materials sales and Choi Jun-mo as head of space solutions business. The number of newly appointed directors rose from one last year to six this year. Last year's reshuffle saw Park Jang-su promoted to executive vice president as chief financial officer, two promotions to senior managing director, one new director appointment and one transfer from an affiliate. "This reshuffle prioritized talent capable of driving the discovery of new growth engines and nurturing future entrepreneurs and leaders to sustain the company's continued growth," an LX Hausys official said.
Nov. 4, 2026
-
Flip-flops, surfboard and a pitch: Jeju founders seek investors at local startup festa
Jeju-based entrepreneurs take on investor challenge 'We'll surpass Patagonia,' founder declares Overseas expansion and growth strategies unveiled Investors scrutinize profitability and potential "We will grow into a global brand that surpasses Patagonia — starting from Jeju." A founder walked into the room wearing flip-flops and carrying a surfboard. Kim Jun-yong, chief executive of Better Than Surf, laid out his ambition to turn a Jeju-born marine leisure brand into a world-class lifestyle label — a far cry from the suit-and-tie atmosphere of a typical IR presentation. The scene unfolded Wednesday at the Sheraton Jeju Hotel, where the 1st Local Startup Festa in Jeju hosted a local investment road show. Entrepreneurs rooted in the region's distinct character stepped forward with their own personalities and business strategies to attract investment. The lineup ranged from a founder dreaming of building a global marine leisure brand out of Jeju to a company helping domestic small and medium-sized enterprises break into overseas markets. Better Than Surf is a local brand built on Jeju's surfing culture and marine leisure, offering functional apparel, casual wear and leisure goods. Kim drew on a background in brand design at Line and Hyundai Card before striking out on his own in Jeju. The road show gave innovative small-business founders a platform to present their business models and growth strategies directly to investors and explore funding opportunities. Founders delivered their own IR pitches, sharing business results and future plans, while investors pressed them on valuation, profitability and growth potential. "I spent about 15 years doing brand design at large companies, but burnout made me rethink my life," Kim said. "I poured the lifestyle I discovered through surfing and running in Jeju into the brand." Kim cited Jeju's distinctive surfing culture and marine leisure scene as the brand's competitive edge. The strategy goes beyond selling products: by combining leisure content with community building, the company aims to cultivate a loyal customer base. Better Than Surf is expanding its product lineup with a focus on functional apparel. "National team athletes and brand ambassadors test and refine the products themselves," Kim said. "We are growing into an authentic brand by building leisure content and community around our products." Sales are rising. Last year's sales came to about 100 million won ($74,600), and Kim projects 200 million to 300 million won this year. Sales in October — typically the off-season — rose 450 percent from the same month a year earlier, Kim said. The brand is also pushing into overseas markets. This year it signed an export deal with Japanese fashion retailer United Arrows, and plans to expand into China, Taiwan and Bali, Indonesia. Domestically, the company intends to extend its offline retail presence beyond Jeju into Seoul and the broader metropolitan area. Kim also unveiled a plan to raise 500 million won ($373,000) in investment. The funds would go toward accelerating development of functional products, expanding production and building distribution networks at home and abroad. Partnerships with strategic production partners are central to the plan, with the goal of improving cost competitiveness and scaling up supply. "We will grow from surfing into leisure, and from a Jeju brand into a global brand," Kim said. "We want to create a lifestyle brand that represents Jeju and earns recognition around the world." Also pitching at the road show was Theyoonsl, a solutions company that helps small and medium-sized enterprises expand overseas. Chief Executive Kim Hyun-ju introduced an export support service linked to more than seven global online marketplaces — including Amazon and eBay — and outlined the company's strategy for growing its international footprint.
Nov. 4, 2026
-
Semiconductor boom lifts equipment and materials firms, with some doubling operating profit
Hanmi Semiconductor posts 90.8 billion won in Q3 operating profit, 50.2% margin Techwing, Vieworks operating profit surges more than 150%; Dongjin Semichem up 51% Hanwha Semitech semiconductor sales jump 115%; analysts eye advanced packaging investment South Korean semiconductor equipment and materials companies posted sharp earnings gains in the third quarter, driven by surging demand for AI chips. As investment in HBM production and advanced packaging expanded, sales and operating profit rose in tandem — particularly among back-end process equipment makers. Some companies more than doubled their operating profit from a year earlier, and the improvement extended to semiconductor materials suppliers and inspection equipment component makers as well. According to DART filings and industry sources, Hanmi Semiconductor recorded consolidated sales of 181 billion won ($135 million) and operating profit of 90.8 billion won in the third quarter of this year, up 8.9 percent and 33.9 percent, respectively, from the same period last year. Its operating profit margin widened 9.4 percentage points to 50.2 percent from 40.8 percent. The earnings drivers were its thermocompression (TC) bonders used in HBM manufacturing and its advanced packaging equipment for AI semiconductors — both high-value-added products. Securities analysts cite the expansion of HBM4 production and the supply of next-generation packaging equipment as key growth factors for Hanmi Semiconductor. Leading Investment & Securities said the company is broadening its product lineup from conventional TC bonders to wide TC bonders and hybrid bonders. Growing equipment orders from customers tied to the HBM4 mass production ramp-up, along with new equipment addressing changes in stacking architecture, could serve as additional growth engines, the brokerage added. Hanmi Semiconductor expects to post its highest-ever fourth-quarter sales, supported by deferred equipment revenue and expanded supply to overseas customers. The company projects it will set a new annual sales record for the third consecutive year, following records in 2024 and 2025. Techwing, a maker of back-end semiconductor inspection equipment, also improved its earnings. The company's third-quarter consolidated sales reached 87.8 billion won, up 110.2 percent year-on-year, while operating profit rose 153.0 percent to 18 billion won. Quarter-on-quarter, sales and operating profit climbed 54.6 percent and 43.9 percent, respectively. Techwing produces memory chip inspection equipment, and the primary growth driver was increased investment in inspection processes tied to the expansion of high-performance memory production, including HBM. Cumulative sales through the third quarter of this year reached 197 billion won, up 57.3 percent from the same period last year. Hanwha Semitech, a subsidiary of Hanwha Vision, swung to a profit on higher semiconductor equipment sales. Its third-quarter consolidated sales came in at 169.8 billion won, up 56.2 percent year-on-year, while operating profit reached 37.3 billion won, reversing a loss from the same period last year. Compared with operating profit of 14 billion won in the previous quarter, that represents a 166.4 percent increase. Semiconductor equipment sales were particularly strong, surging 115.2 percent to 84.8 billion won from 39.4 billion won a year earlier. Nam Chae-min, a researcher at Korea Investment & Securities, said revenue from about 60 billion won worth of panel-level packaging equipment orders secured this year is being recognized faster than initially expected, and that flip-chip bonders for DDR5 packaging will serve as an additional growth driver next year. Semiconductor materials supplier Dongjin Semichem also improved its results. The company's third-quarter consolidated sales, disclosed Tuesday, totaled 370.8 billion won, up 23.6 percent year-on-year, while operating profit rose 51.2 percent to 61.1 billion won. The operating profit margin improved roughly 3 percentage points to about 16.5 percent from about 13.5 percent a year earlier. Dongjin Semichem supplies materials used in semiconductor manufacturing processes, including photoresists, thinners and anti-reflective coatings. Unlike equipment makers, whose results are influenced by the timing of customers' capital expenditure cycles, materials suppliers are more directly affected by changes in semiconductor output volumes and process complexity. Vieworks, a specialist in industrial imaging equipment, also improved its profitability on the back of growth in its semiconductor inspection-related business. Third-quarter consolidated sales reached 61.6 billion won and operating profit came in at 11 billion won, up 14.7 percent and 154.8 percent, respectively, from a year earlier. Sales of industrial machine vision cameras — used in semiconductor inspection equipment and other applications — were a particular bright spot, rising 89.7 percent to 18.7 billion won from 9.9 billion won in the same period last year. Order backlogs at front-end process equipment makers are also growing. As of the end of the first half of this year, Tes had an order backlog of about 206.9 billion won, Eugene Technology about 153.3 billion won, and Jusung Engineering's semiconductor equipment backlog stood at about 214.4 billion won.
Nov. 4, 2026
-
'Era of building tourist spots is over': Local entrepreneurs must create travel destinations
Panel discussion at the 1st Local Startup Festa in Jeju explores how local businesses can drive regional economies Local firms must grow in ways that benefit their communities, speakers say Designing place-based experiences is where local entrepreneurs outshine big companies Panelists see major opportunities ahead for local businesses "Local entrepreneurs must turn their regions into new travel destinations." Park Jun-gyu, CEO of Surfybeach, made the call Wednesday at a panel discussion held during the 1st Local Startup Festa in Jeju at the Sheraton Hotel in Jeju. "The era when government agencies had to build tourist attractions before visitors would come is over," Park said. "Local entrepreneurs must use diverse, place-rooted businesses to turn their regions into travel destinations." Local startups need business models that contribute to regional economies Park noted that the travel industry underwent a fundamental shift around July 2014, when Instagram hashtags emerged as a force in shaping where people go. "Even a place with nothing to offer can become a new travel destination if you create just one leisure or experiential space," he said. He pointed to Surfybeach, the brand he founded, as a prime example. Built around a beach near Hajodae in Yangyang-gun, Gangwon Province, Surfybeach combines surfing, marine leisure and cultural content into a local brand. Through surf lessons, a beach bar, performances and festivals, it played a major role in putting Yangyang on the map as one of South Korea's leading surf tourism destinations. "Yangyang used to be just a road you passed through on the way to Gangneung or Sokcho," Park said. "I started Surfybeach with the idea of bringing something new to Korean beaches, which had offered nothing but beach umbrellas and inflatable tubes for 40 or 50 years." On government support for local businesses, Park said it was only fair that entrepreneurs receive public funding when their ventures genuinely benefit the community. He particularly stressed the importance of building a business model that contributes to the local economy while navigating the so-called "death valley" — the grueling early phase of establishing a foundation and winning customers. Local businesses create new commercial opportunities by drawing on a region's distinctive natural environment and culture. The government, recognizing that the growth of individual firms can draw tourists and revitalize surrounding commercial districts, has been stepping up support for local startups as a new engine of regional economic growth. "I believe that fair local entrepreneurship means that once you launch a business and survive the death valley, you give back to the region," Park said. "If that happens, a local startup could itself become a kind of 'festa.'" 'Designing local experiences is where entrepreneurs beat big companies' Mo Jong-rin, a Yonsei University professor who also attended the panel, weighed in on the growth potential of local industries, using singer Lee Hyo-ri's moves to and from Jeju Island as a lens. "Lee Hyo-ri relocated to Jeju Island in 2013, and around that time the island's population began to grow — a phenomenon people started calling 'Jeju migration,'" Mo said. "When Lee left Jeju in 2024, people began saying the island had lost its old charm." Mo said Korean society began drifting back toward materialism around 2017. "Seoul real estate prices surged and interest in asset investment soared, strengthening a preference for Seoul over the regions," he said. He added that the expansion of online markets has put pressure on offline industries across the board, making it hard to call the environment for local businesses truly favorable. Still, he said it was encouraging that local firms had accumulated diverse experience and built a track record of success stories. Mo also cited growing government support for local startups as a factor boosting their prospects. "Local entrepreneurship was included in the previous administration's national policy agenda, and the current government is actively supporting it as well," he said. He particularly highlighted the ability to offer place-specific experiences as a key competitive edge for local businesses. "Ultimately, we are people who design customers' time and experiences," Mo said. "Designing experiences rooted in a place is an area where local entrepreneurs can outperform large companies." "As the experience economy grows in importance, the future of the retail industry will also point toward local," he added. "I believe bigger opportunities are coming for local businesses." Meanwhile, panelists also raised the need for workforce support to help local businesses scale further. Yang Je, CEO of Medals, a Jeju-based citrus brand, said talent recruitment was such a pressing concern that the company had opened a Seoul office just to access a wider pool of candidates. "We need a foundation for cultivating talent region by region," Yang said.
Nov. 4, 2026
-
Gov't extends loan repayment grace period by 1 year for firms hit by Tmon-WeMakePrice crisis
Financial relief for firms affected by 2024 Tmon-WeMakePrice crisis Grace period on principal repayment of emergency stabilization loans extended by 1 year Firms with short-term arrears of 30 days or less also eligible Applications accepted through Feb. 26, 2027 The Ministry of SMEs and Startups will extend by one year the grace period on principal repayment of policy loans for small and medium-sized enterprises affected by the Tmon-WeMakePrice crisis. The ministry announced Wednesday it would implement a "special maturity extension on policy loans for firms affected by the Tmon-WeMakePrice crisis." The measure comes as repayment deadlines approach for SMEs that received emergency business stabilization loans during the 2024 Tmon-WeMakePrice crisis, raising concerns that their financial burden could intensify. The ministry disbursed emergency business stabilization loans through its Tmon-WeMakePrice victim support program from September through December 2024. The loans were structured with a two-year principal repayment grace period followed by repayment spread over three years, meaning grace periods for affected firms have been expiring in sequence this year. Eligible for the special maturity extension are SMEs that received emergency business stabilization loans through the 2024 Tmon-WeMakePrice victim support program. The extension will apply to the Tmon-WeMakePrice support loans those firms received. Firms that have fallen into short-term arrears of 30 days or less on their SME policy loans are also eligible, extending relief to businesses struggling with principal repayment due to temporary cash-flow difficulties. Qualifying firms may extend their principal repayment grace period by an additional year. No minimum principal repayment condition will be imposed during the extension, and no additional interest rate premium will be charged. Concerns have emerged that firms which weathered the immediate liquidity crisis after the Tmon-WeMakePrice incident through emergency stabilization loans could face renewed financial pressure as repayment deadlines arrive. The measure is intended to ease the burden on affected firms of having to raise additional funds to service existing loans and to give them more time to restore normal operations. Applications for the special maturity extension will be accepted from Wednesday through Feb. 26, 2027. Details are available on the Korea SMEs and Startups Agency website. Consultations are also available through regional Korea SMEs and Startups Agency offices and branches or through the integrated SME call center. "We expect this measure to help reduce the temporary liquidity burden on small and medium-sized enterprises affected by the Tmon-WeMakePrice crisis and support their return to normal operations," said Shim Jae-yun, director general for global growth policy at the ministry.
Nov. 4, 2026
-
7 in 10 Homeplus suppliers hit by store closures, sales slump: survey
72% of Homeplus suppliers report losses, vs. 2% at E-mart and 8% at Lotte Mart 63% of Homeplus suppliers see sales drop; direct-purchase margin at 20.2% 72% of Homeplus private-brand suppliers report lower operating profit Seven in 10 small and medium-sized enterprises supplying Homeplus reported losses due to the chain's operational changes, including store reductions, a new survey shows. Some 63 percent said their sales had declined — a higher rate than suppliers reported at any other major hypermarket. According to the Korea Federation of SMEs' "2026 Survey on Trading Conditions for SMEs in Offline Large-Scale Retail Outlets," released Wednesday, 72 of 100 surveyed Homeplus suppliers — 72 percent — said they had been hurt by the chain's operational strategy changes, including store downsizing and closures. That figure far exceeded the rates at E-mart (2 percent), Lotte Mart (8 percent) and Hanaro Mart (6 percent). All 72 Homeplus suppliers that reported losses cited delayed payment settlements as a form of harm. Sales declines were also pronounced. Some 63 percent of Homeplus suppliers said their sales fell compared with the previous year. Only 6 percent reported an increase, while 31 percent said sales were unchanged. The gap with other hypermarkets was wide. The share of suppliers reporting sales declines was 28 percent at E-mart, 31 percent at Lotte Mart and 26 percent at Hanaro Mart. Hanaro Mart had the highest share of suppliers reporting sales growth at 22 percent, followed by Lotte Mart at 12 percent, E-mart at 8 percent and Homeplus at 6 percent. Across all four hypermarkets, 37 percent of the 400 surveyed SMEs reported lower sales, while 12 percent reported growth and 51 percent saw no change. Homeplus suppliers' sales-decline rate was 26 percentage points above the overall average. Assessments of trading conditions also differed. Some 18 percent of Homeplus suppliers said conditions had worsened over the past two years, compared with 13 percent at Lotte Mart and 8 percent each at E-mart and Hanaro Mart. The average margin rate on direct-purchase transactions — in which a hypermarket buys products outright — was 21 percent across all chains. The margin rate is calculated as the difference between the shelf price and the supplier's delivery price, expressed as a share of the shelf price. By chain, Lotte Mart posted the highest average margin rate at 23 percent, followed by E-mart at 21.7 percent, Homeplus at 20.2 percent and Hanaro Mart at 19.2 percent. Among the 90 Homeplus direct-purchase suppliers surveyed, individual margin rates ranged from a low of 10 percent to a high of 40 percent. The average sales commission rate for suppliers operating under special-purchase or lease arrangements was 20.2 percent. Lotte Mart was highest at 23.1 percent, followed by Homeplus at 21.8 percent, Hanaro Mart at 15.6 percent and E-mart at 15 percent. However, only 36 suppliers across all chains used these arrangements, including just 10 at Homeplus, so the figures should be interpreted with caution. Small businesses supplying Homeplus with private-brand products also fared poorly. Among 25 Homeplus private-brand suppliers, 72 percent said both sales and operating profit had declined from the previous year. The comparable figures were 20.6 percent for E-mart private-brand suppliers, 23.5 percent for Lotte Mart and 20.8 percent for Hanaro Mart. Among all 117 private-brand suppliers across the four hypermarkets, 32.5 percent each reported declines in sales and operating profit. Only 14.5 percent reported increases. The survey was conducted from July 20 to Oct. 1, covering 100 SMEs each from E-mart, Lotte Mart, Homeplus and Hanaro Mart, for a total of 400 companies.
Nov. 4, 2026
-
KCC attends SEMA Show for second consecutive year, showcasing automotive refinish paints
Only Korean paint firm at show, running through Friday in Las Vegas Water- and oil-based paints, AI-powered digital color-matching technology on display North America customer expansion tied to Dallas color center KCC announced Wednesday it will participate in the SEMA Show, an automotive aftermarket exhibition in Las Vegas, for the second consecutive year — the only Korean paint company to do so. Running Tuesday (local time) through Friday at the Las Vegas Convention Center, the SEMA Show is a business-to-business exhibition showcasing products and technologies related to auto parts, tuning, painting and repair. The event draws more than 100,000 industry professionals from over 100 countries each year, with more than 2,000 companies taking part. KCC will present its water-based automotive refinish paint Sumix and oil-based paint Baromatch, along with clearcoat products and refinishing accessories. The company will also demonstrate Color-Navi Plus, an AI-powered color solution that analyzes vehicle color data measured by a spectrophotometer to search for similar shades, generate mixing formulas and automatically correct color. KCC will also introduce CR6, an automated color-mixing system. KCC established a Refinish Color Center in Dallas, Texas, in 2023 to conduct color-mixing research for automotive refinish paints and provide local technical support. The company plans to use the exhibition to consult with local buyers and expand its customer base in North America. "We will broaden our business foundation in the North American market, drawing on our diverse product lineup and the technical support capabilities of our US Refinish Color Center," a KCC official said.
Nov. 4, 2026
-
Ildong Bioscience wins gold at Korea Food Research Institute's technology awards
Korea Food Research Institute's 'Food Technology Award' gold prize Ildong Bioscience has received official recognition for its technology spanning the generation and activation of beneficial gut microorganisms through to the supply of effective metabolites. The company develops and sells a combined biotics health supplement called "GQ Lab Pro·Pre·Postbiotics," built around probiotics — live beneficial gut bacteria. The product combines probiotics with prebiotics, which serve as food for the bacteria and promote their growth and activity, and postbiotics, which are metabolic byproducts that deliver health benefits, all in a single product. Taking into account the characteristics of each of the three ingredients, Ildong Bioscience applied a differentiated formulation technology in which probiotics and prebiotics are in powder form while postbiotics are in granule form. The company also developed a separation and quantification technology that exploits the difference in particle size between granules and powder, enabling independent management of each ingredient. In addition, the company applied a live-bacteria protective coating technology to the probiotic ingredient to enhance stability during manufacturing and retail. The postbiotics were granulated to improve ingredient quality control and ease of consumption. Ildong Bioscience won the gold prize Wednesday at the Korea Food Research Institute's 2026 Food Technology Award ceremony, with the recognition affirming the competitiveness of its combined biotics ingredients, technology and product. "We will focus on research and development to introduce beneficial health supplement ingredients and products with high quality and functionality," a company official said.
Nov. 4, 2026
-
Local startup festa kicks off in Jeju, connecting regional firms with global investors
Nationwide local startup event runs Wednesday through Friday in Jeju Domestic and overseas investors, retailers and buyers gather under one roof Support spans brand development, local commerce and global market entry Local companies built on regional resources and ideas have gathered in Jeju to explore investment opportunities and pathways into overseas markets. The government said it will strengthen stage-by-stage support to help local firms drive commercial revitalization and export expansion. The Ministry of SMEs and Startups held the opening ceremony of the first Local Startup Festa in Jeju at the Sheraton Jeju Hotel on Wednesday, with events running through Friday across the old downtown area of Jeju. Co-hosted by the ministry and Jeju Special Self-Governing Province, the event carries the slogan "From local to global, regional value into the future." About 140 local companies from across the country are taking part, alongside eight domestic investment firms, three overseas investors, five major brands and retailers, and 13 foreign buyers. The event focuses on linking brand development, private investment attraction, local commercial revitalization and global market entry into a single growth pathway for local firms. Rather than limiting itself to product exhibitions or business networking, the program is designed to directly connect companies with investors, retailers and overseas buyers to generate concrete business opportunities. According to the ministry, 765 local startup small businesses attracted a combined 122.7 billion won ($91.5 million) in private investment through the LIPS (Linked Investment and Policy Support) program from 2023 through August this year. Under LIPS, the government provides policy funding and commercialization support after a private investor makes an initial investment in a high-potential small business. The export participation rate among these companies rose from 12 percent in 2023 to 22.7 percent last year, while average exports per company climbed from 183 million won to 233 million won over the same period. Wednesday's opening day, themed "From region to brand," features sessions where local companies share their growth stories and investment strategies. The opening ceremony includes commendations for individuals who contributed to nurturing local businesses, followed by a vision performance. A panel discussion titled "Asking about local" will then bring together experts and entrepreneurs — including Mo Jong-rin, a professor at Yonsei University, and Park Jun-gyu, chief executive of Surfer Beach — to discuss the current state and future direction of the local industry. The afternoon program is dedicated to connecting investors with local companies. The "Local Investment Road Show" features reverse pitching, in which investors present their areas of interest and investment strategies first, followed by IR sessions from six local firms. The top three local companies selected through a public vote — dubbed "Local Star TOP3" — will also be unveiled. Thursday's program focuses on spreading local companies' achievements into regional commercial districts. Sessions including a "Local Commerce Talk" and a "Local Commerce Outcomes Sharing" event will highlight successful commercial district cases and the results of commerce-linked crowdfunding campaigns. A "Commerce Insight Trip" will take participants on visits to commercial districts in downtown Jeju and Seogwipo. An innovative finance program discussing new funding tools for small businesses — including security token offerings (STO) — and a forum for commercial district planners from across the country to collaborate will also be held. The final day, Friday, centers on expanding domestic and overseas sales channels for local companies. The program will showcase collaboration cases between local firms and major brands and retailers such as Ottogi and Black Yak, with discussions on joint product development and distribution network opportunities. One-on-one consultations will be held with participants including Invest Hong Kong and overseas buyers. An export showcase will highlight local companies' overseas achievements, with plans to pursue letters of intent from foreign buyers and the signing of export contracts. Throughout the event, an exhibition and sales space will allow visitors to browse and purchase products from local companies nationwide. The event has drawn attention for bringing together under one roof what had previously been separate efforts — local company development, investment attraction, commercial revitalization and overseas expansion support. As local firms from across the country meet directly with domestic and foreign investors, major retailers and overseas buyers, industry observers are watching closely to see whether the gathering will translate into tangible outcomes such as new business partnerships, investment deals and export contracts. A key challenge going forward will be ensuring that the relationships formed at the event lead to sustained sales growth and regional economic vitality, rather than remaining a one-time exchange. Lee Byeong-gwon, second vice minister of SMEs and Startups, said it is important to "densely connect the growth pathway so that a company that started from a small regional idea can grow into a competitive brand, find investment and new sales channels, and take on the global market." He added that the ministry would "actively support this festa in providing local companies with new investment, sales and export opportunities, and in ensuring that their growth feeds back into the vitality of local commerce and regional economies."
Nov. 4, 2026
-
Boram Carnegie signs funeral service MOU with Mokwon University
Four special products for faculty, spouses, parents and children Pay-after-service model with no monthly premiums Deal builds on existing ties with Boram Hallelujah table tennis team Boram Carnegie, a business-to-business funeral service company under Boram Group, announced Wednesday it has signed an employee welfare MOU with Mokwon University. Under the agreement, signed at Mokwon University in Daejeon on Oct. 27, faculty and staff — along with their spouses, parents from both sides of the family and children — will have access to Boram Carnegie's specially discounted funeral service products. The offering comprises four products, all structured on a pay-after-service model that requires no monthly premiums. When a funeral occurs, customers use the service first and settle the cost afterward, paying by cash or card once they have reviewed the itemized service record. The MOU grew out of an existing relationship between Mokwon University and Boram Hallelujah, Boram Group's professional table tennis team. The two sides signed a community-contribution and event-promotion agreement in May and have since co-hosted activities including a "Sarang-ui Saemteo" charity event supporting international and multicultural students. Boram Carnegie has recently signed similar funeral service agreements with the Seoul Metro Environment Branch and Seoul Urban Railway Green Environment Branch of the National Environment and Labor Union, as well as the Daewoo Engineering & Construction branch of the National Construction Industry Workers' Union. "We will make sure that Mokwon University faculty and their families can access funeral services even in sudden, unexpected situations," said Kim Gyeong-gon, chief executive of Boram Carnegie.
Nov. 4, 2026
-
DaedongGear hits upper limit, Daedong surges on Hyundai Motor robot farm project
Saemangeum robot farm factory plan discussed at National Assembly forum 300 billion won earmarked for 2027–2031; agricultural robots to be built, trained and field-tested on site Daedong Group expands agricultural physical AI business; DaedongGear also pursues robot parts development Shares of agricultural machinery maker Daedong and its affiliate DaedongGear surged Wednesday after news emerged that Daedong Group had joined Hyundai Motor Group in discussions over a 300 billion won ($224 million) Saemangeum Robot Farm Factory project, fueling expectations of a major expansion into agricultural robotics. According to industry sources, a forum to advance the Saemangeum Robot Farm Factory initiative was held Tuesday at the National Assembly members' office building. The event, hosted by Democratic Party of Korea lawmaker Park Ji-won and co-organized by North Jeolla Province and Gimje, drew about 30 participants, including representatives from Hyundai Motor Group, Daedong Group, the Ministry of Agriculture, Food and Rural Affairs, the Ministry of Trade, Industry and Energy, and academic and research institutions. At the forum, participants presented a plan to build an industrial complex in the Saemangeum area where agricultural robots could be manufactured, trained and field-tested under one roof. The core concept is to develop farm-specific robots, accumulate operational data on actual farms and translate that into commercial products. The project envisions investing a total of 300 billion won in a 21-hectare site in Gimje, North Jeolla Province, within the Saemangeum zone, with funding running from 2027 to 2031. The proposed financing structure calls for 180 billion won in national government funds, 60 billion won from local governments and 60 billion won in private capital. The breakdown allocates 120 billion won to a "Demo Dark Factory" — an unmanned robot production facility — 80 billion won to a "Robot Farm Data Factory," and 100 billion won to a 16-hectare demonstration complex. Daedong Group Executive Director Chung Ju-yung presented the project's direction under the theme "Farming Built by Robots: The Robot Farm Factory." Hyundai Motor Group Executive Director Song Ho-deuk outlined a strategy for building a robot ecosystem in Saemangeum. Daedong Group Vice Chairman Won Yu-hyun also attended the forum. The project could be linked to Hyundai Motor Group's Saemangeum investment plan announced in February, under which the group said it would invest around 9 trillion won to build an AI data center, robot manufacturing facilities and hydrogen production infrastructure in the zone. However, the investment amounts by individual companies and the specific division of roles for the robot farm factory project have yet to be finalized. Daedong has been expanding into AI tractors and agricultural robotics on the back of its farm equipment manufacturing business. At its "2026 Daedong Tech Day" held in April, the company unveiled an AI tractor and an autonomous transport robot, and announced a strategy to shift from machinery sales toward a data- and service-based agricultural operations business. DaedongGear has also moved into robot components. In April, the company launched a rights offering of about 80 billion won and disclosed an investment plan targeting electric vehicle and robot parts. It plans to develop reducers and actuators for robots by drawing on its existing transmission and precision machining expertise. A Daedong official said the robot farm factory to be built in Saemangeum would be an advanced facility managed entirely by robots. "With the collaboration with Hyundai Motor now confirmed, it appears that rising expectations are driving the sharp jump in our share price," the official said. As of 9:45 a.m. Wednesday, DaedongGear's share price had hit the daily upper limit, while Daedong was up more than 17 percent.
Nov. 4, 2026
-
TYM posts W35.8b operating profit in Q3, up 125% on year
Q3 sales reach 260.1 billion won, up 16% on year Cumulative operating profit for first three quarters rises 78% to 98.4 billion won Growth driven by North America mid- to large-size tractor sales expansion and improved product mix Agricultural machinery manufacturer TYM said Wednesday its third-quarter consolidated operating profit rose 124.7 percent from a year earlier to 35.8 billion won ($26.7 million). Sales for the quarter reached 260.1 billion won, up 16.0 percent on year, while net profit for the period climbed 78.9 percent to 20.1 billion won. For the first three quarters of this year combined, TYM posted cumulative sales of 812.3 billion won, up 14.0 percent from the same period last year. Cumulative operating profit grew 78.0 percent to 98.4 billion won, and cumulative net profit for the period rose 125.2 percent to 76.8 billion won. TYM said the earnings improvement was driven by the introduction of strategic models in the North American market and a higher share of mid- to large-size tractor sales. The company also strengthened its local logistics and customer support network by establishing a new assembly facility in Pennsylvania and an integrated service and parts hub in Georgia. Last month, TYM won the Gold Level Award in the tractor category at the 2026 Dealer Satisfaction Survey organized by the North American Equipment Dealers Association. The company ranked first overall in customer satisfaction for two consecutive years and received top industry ratings in nine of 12 evaluation categories. "We will continue to grow by strengthening product quality and customer support capabilities and pursuing strategies tailored to the characteristics of each market," said Kim So-won, TYM's chief executive.
Nov. 4, 2026
-
KCC Glass expands ESG disclosure to overseas operations, reveals Indonesia unit data for first time
'2025/26 ESG Report' published — sixth consecutive edition Biodiversity impact assessment results released for Gapyeong, Yeongwol factories EcoVadis awards top 'Platinum' rating, placing firm in top 1% KCC Glass has disclosed the environmental, social and governance management performance of its overseas operations for the first time, while expanding the scope of its domestic ESG reporting to include strengthened biodiversity impact assessments. The company announced Wednesday that it had published its "2025/26 ESG Report" reflecting these developments. The report, the sixth consecutive edition, details progress on 12 strategic tasks and 24 action items aligned with the company's ESG goals. It particularly strengthens disclosure on natural capital and biodiversity, and for the first time incorporates ESG management data from its overseas subsidiaries. KCC Glass used World Wildlife Fund criteria to identify biodiversity risk factors and applied ENCORE, an analytical tool recommended by the Taskforce on Nature-related Financial Disclosures, to assess the company's dependence on and impact on natural capital across its business activities. The report also discloses biodiversity impact assessment results for areas surrounding key domestic sites, including the Gapyeong and Yeongwol factories. The company analyzed ecological impacts on the surrounding environment using post-environmental impact survey data and incorporated field investigation findings into the report. Disclosure on overseas operations was also expanded. The report includes, for the first time, ESG management performance data from the company's Indonesian subsidiary — covering greenhouse gas emissions, energy use management, environmental management system operations and environmental investment results. Social performance data, including occupational health and safety management, labor-management cooperation and community contribution activities, are also included, along with quantitative indicators on key raw material usage and workforce figures. The report incorporates a double materiality assessment that considers both the financial value of the business and its environmental and social impacts. It also discloses the company's climate change response in line with recommendations from the Task Force on Climate-related Financial Disclosures. Among future growth technologies, the report highlights smart glass with adjustable transparency and glass substrates for semiconductors, both currently under development. KCC Glass has also posted strong results in external ESG evaluations. The Korea Institute of Corporate Governance and Sustainability rated the company an integrated A for three consecutive years from 2023 through last year. In last year's assessment, it received an A in all three categories — environment, social and governance. In this year's assessment by global sustainability rating agency EcoVadis, KCC Glass earned a Platinum rating — the highest designation, awarded to the top 1 percent of evaluated companies. The result marks a step up from the Gold rating, which places firms in the top 5 percent, that the company had received for three consecutive years. KCC Glass also ranked 25th among companies with assets of 2 trillion won ($1.49 billion) or more in Sustinvest's "ESG Best Companies 100 for the First Half of 2026." "We will continue our efforts to strengthen the execution of ESG management and faithfully disclose our performance to stakeholders through our report," a KCC Glass official said.
Nov. 4, 2026
-
Hanmi Semiconductor chair buys additional W10b in company shares
Open-market purchase set for Dec. 2; stake to reach 33.69% upon completion Cumulative purchases since 2023 to hit 80.2 billion won; controlling shareholder deepens commitment HBM TC bonder demand seen rising; company on track for record sales for third consecutive year Hanmi Semiconductor Chairman Kwak Dong-shin plans to invest 10 billion won ($7.46 million) of his personal funds to buy additional shares in the company — his fifth such purchase this year. Once completed, his cumulative share purchases since 2023 will total 80.2 billion won. Hanmi Semiconductor announced Wednesday that Kwak plans to buy 10 billion won worth of company shares on the open market on Dec. 2. His stake is expected to rise from the current 33.63 percent to 33.69 percent upon completion. Kwak has bought Hanmi Semiconductor shares four times already this year — 3 billion won in April, 8 billion won in June, 5 billion won in July and 700 million won in October. Including the latest 10 billion won purchase, his total outlay for the year will reach 26.7 billion won. In October, Kwak bought 2,549 shares for about 700 million won on the open market at an acquisition price of 274,235 won per share, lifting his stake to 33.63 percent. His cumulative purchases since 2023 stood at 70.2 billion won at that point. The company said the repeated share purchases reflect Kwak's commitment to responsible management as the controlling shareholder and his confidence in the company's value. Hanmi Semiconductor has sustained earnings growth on the back of expanding investment in AI semiconductor markets and HBM manufacturing facilities. The company expects to set a new annual sales record this year, following records in 2024 and 2025. Growing demand for TC bonders driven by higher stack counts in next-generation HBM is cited as a key growth driver. Hanmi Semiconductor also plans to expand supply of new TC bonders, FC bonders and Micro Saw & Vision Placement equipment used in large-area AI packaging processes. The company is also pushing into overseas markets. In October, Hanmi Semiconductor established a local subsidiary, Hanmi USA, in San Jose, California. The new outpost follows existing subsidiaries in Taiwan, China and Singapore, and is intended to strengthen technical support and semiconductor equipment supply for local customers. "Chairman Kwak's additional share purchase reflects his confidence in the company's technological capabilities and future growth, as well as his commitment to responsible management as the controlling shareholder," a Hanmi Semiconductor official said. "We will continue to enhance corporate and shareholder value through our entry into the US market and the expansion of advanced packaging equipment supply." Meanwhile, Hanmi Semiconductor's share price stood at 127,400 won at the end of last year before soaring to an intraday high of 426,000 won in May, then reversing course. By late October it had fallen back to the 180,000 won range. On Tuesday, the stock closed at 180,000 won, down 6.10 percent from the previous session.
Nov. 4, 2026
-
Seoul St. Mary's Hospital uses AI to predict chronic kidney disease risk
Combining health checkup, genomic and wearable data Clinical trial of 50 participants aims to support personalized health management Seoul St. Mary's Hospital has begun clinical validation of a mobile app that uses AI and wearable devices to predict chronic kidney disease risk. The technology integrates health checkup results, genomic data and daily health metrics to assess disease risk and provide personalized health management support. Catholic University of Korea Seoul St. Mary's Hospital announced Wednesday that a research team led by Lee In-seok, a professor in the gastroenterology department, has launched a clinical validation study to evaluate the effectiveness of the AI-based chronic kidney disease risk prediction app. The research is part of the "AI-Based Personalized Care Service Convergence Leading Project," funded by the Ministry of Science and ICT and the Institute for Information and Communications Technology Planning and Evaluation. The project aims to develop AI technology that analyzes individual health conditions and lifestyle habits to predict the onset and progression of disease. Central to the approach is what the team calls "phenome data" — a comprehensive picture of a person's biological characteristics and health status shaped by the interaction between genetic information and environmental factors. The data encompasses clinical measurements such as blood pressure and blood sugar levels, as well as lifestyle information including medical history, sleep patterns and physical activity. The research team is developing an AI model that links electronic medical records from multiple hospitals with health checkup data, then combines that with genomic analysis and wearable-collected metrics — including physical activity, sleep and heart rate — to predict disease risk. Conventional disease risk prediction models focus on calculating the likelihood of illness based on a patient's health status at a single point in time. The technology under development, by contrast, continuously incorporates changes in an individual's health condition and lifestyle to also deliver personalized health management guidance. To that end, activity, sleep and heart rate data collected via Samsung Electronics' Galaxy Watch are analyzed on an AI patient health platform called PHAIR. The app provides chronic kidney disease risk assessments alongside personalized coaching features designed to help users improve their lifestyle habits. The system also employs federated learning technology, which allows multiple hospitals to jointly train an AI model without directly sharing patient data. The research team began clinical validation in October, recruiting 50 participants who will use the mobile app and wearable device for three months. At the three-month mark, kidney function will be assessed through follow-up blood tests. The full study runs for six months. The team plans to evaluate the app's usability, user satisfaction and overall utility to determine whether it can serve as a practical health management tool in everyday life. The study involves Seoul St. Mary's Hospital, Catholic University of Korea's Department of Medical Informatics, Digital Farm and Pyeonghwa Is. The Department of Medical Informatics is responsible for developing AI models to predict the risk of chronic kidney disease and lung cancer, while Digital Farm handles AI analysis and platform operations. "This research examines whether AI and wearables can deliver the kind of continuous risk monitoring and feedback that outpatient care alone has struggled to provide — and tests that in a real clinical setting," Lee said. "We hope this study will help connect advanced technology to patient-centered care, reducing suffering and improving quality of life." Meanwhile, Seoul St. Mary's Hospital signed an MOU in June with Asan Medical Center, the National Cancer Center, Chung-Ang University Hospital and Konkuk University Hospital to strengthen cooperation on medical AI. As part of a medical data hub hospital support project, the participating institutions agreed to pursue AI model performance validation using real clinical data, application in clinical settings and expanded collaboration with industry partners.
Nov. 4, 2026
-
Samsung Biologics earns top 'Negligible' ESG risk rating from Sustainalytics
Ranks 4th among 842 global pharmaceutical companies, placing in top 0.5% Scores 9 points across environment, social and governance management Adds to top marks from MSCI and EcoVadis this year Samsung Biologics has earned the highest possible rating from Sustainalytics, the global ESG risk assessment firm. The biopharmaceutical company announced Wednesday it received a Negligible rating — the top tier in Sustainalytics' 2026 ESG Risk Rating, indicating an extremely low level of unmanaged ESG risk. Sustainalytics, a subsidiary of Morningstar, annually assesses the non-financial risk profiles and management practices of approximately 16,000 companies worldwide. Under its five-tier rating system, a lower risk score indicates stronger performance, and the Negligible designation is reserved for companies that score below 10. Samsung Biologics recorded a total score of 9, moving up one tier from the Low Risk rating it received the previous year. The company ranked 4th out of 842 pharmaceutical companies evaluated globally, placing it in the top 0.5 percent of the industry. In the environmental category, the company pursued environmental audits and developed plans for hazardous waste recycling. On the social front, it strengthened transparency by establishing diversity policies and publicly disclosing quality and safety targets. In governance, it advanced its management framework through ethics audits and the setting of board diversity goals. Earlier this year, Samsung Biologics received a Platinum rating from EcoVadis in January, placing it in the top 1 percent of assessed companies. In May, it was included in the Dow Jones Best-in-Class World Index for the fifth consecutive year, and in September it earned an A rating in the MSCI ESG assessment. "This is the result of consistently advancing our company-wide ESG risk management framework," said John Rim, chief executive of Samsung Biologics. "We will continue to uphold responsible management and transparent disclosure to further strengthen the trust of our global stakeholders." The latest rating is expected to sharpen Samsung Biologics' competitive edge as it competes for contract development and manufacturing deals with global pharmaceutical majors that increasingly demand high ESG standards.
Nov. 4, 2026
-
TIPA supports 16 defense and strategic-tech SMEs in attracting investment
Investor presentation held jointly with Industrial Bank of Korea, Hana Bank SMEs selected from Ministry R&D performers based on technology and market assessments The Korea Technology and Information Promotion Agency for SMEs announced Wednesday that it held its sixth SME R&D dedicated-bank investor presentation of 2026 to support small and medium-sized enterprises in the defense and national strategic technology sectors in attracting investment. The two-day event ran from Tuesday at TIPA's Greater Seoul evaluation center, with Industrial Bank of Korea and Hana Bank — the designated banks for SME research and development fund deposits — taking part. TIPA accepted applications in September from companies that had carried out R&D projects under the Ministry of SMEs and Startups, then evaluated their technological and market potential to select 16 firms. The selected companies made in-person investor relations presentations to investment reviewers from both banks. Companies that draw the reviewers' interest will go through follow-up meetings before a final investment decision is made. "We will strengthen the support framework that links technology development, commercialization and investment attraction in cooperation with the SME R&D dedicated banks," TIPA Director General Kim Young-sin said.
Nov. 4, 2026
-
Kibo expands tech guarantees for fire industry SMEs, cuts guarantee fees
Kibo signs MOU with Korea Fire Industry Technology Institute Fire safety tech firms added to 'Safety Infrastructure Guarantee' program Enhanced financial support includes preferential guarantee ratios, fee reductions Korea Technology Finance Corporation has signed a memorandum of understanding with the Korea Fire Industry Technology Institute to expand financial support for small and medium-sized enterprises in the fire industry, Kibo announced Wednesday. The two organizations signed the MOU — titled "Business Agreement for Strengthening the Foundation of the Fire Industry Ecosystem" — on Tuesday at Kibo's Human Resources Development Institute in Yongin, Gyeonggi Province. Under the agreement, the Korea Fire Industry Technology Institute will identify and recommend outstanding companies in the fire industry sector to Kibo, which will then provide technology guarantees to those recommended firms. Kibo plans to add companies with superior fire safety technology to the existing pool of beneficiaries under its Safety Infrastructure Guarantee program, offering preferential guarantee ratios and reduced guarantee fees. Eligible companies include those that have received type approval, performance certification or KFI certification from the Korea Fire Industry Technology Institute for fire-fighting equipment, as well as firms certified for hazardous materials products, fire-fighting equipment and flame-retardant performance testing. "We will leverage the institute's expertise and Kibo's technology finance capabilities to support the management stability and competitiveness of small and medium-sized enterprises in the fire industry," Kibo Chairman Kwon Hyung-taek said.
Nov. 4, 2026
-
National Growth Fund biotech support tops W800b with blood product approval for GC Biopharma
GC Biopharma wins 170 billion won low-interest loan for US-bound 20% SCIG production and clinical trials; direct biotech approvals reach 825 billion won across five companies; Alteogen's 200 billion won indirect investment counted separately The National Growth Fund, a policy finance vehicle established by the government and financial sector to nurture advanced strategic industries, is channeling large-scale funding into the domestic biotech sector's core production infrastructure and drug development pipelines. Starting with Btigen (formerly STgen Bio) as its first biotech recipient in April, the fund has since extended support to SK Bioscience, LigaChem Biosciences, Kyongbo Pharmaceutical and now GC Biopharma — each cleared by the fund's investment review committee — pushing the cumulative total of directly approved biotech support to more than 800 billion won ($597 million). According to financial regulators and the Korea Biotechnology Industry Organization, the fund's investment review committee approved Thursday a 170 billion won low-interest loan for GC Biopharma, which is building next-generation blood product manufacturing capacity at its Ochang factory in Cheongju, North Chungcheong Province, and advancing US clinical research and development. The loan, drawn from the Advanced Strategic Industry Fund, covers 170 billion won of the project's total cost of 210 billion won. GC Biopharma said it will direct the funds toward a global Phase 3 trial of a high-concentration 20% subcutaneous immunoglobulin (SCIG) targeting the US market and toward building production facilities at the Ochang factory. The company aims to submit an investigational new drug application to the US Food and Drug Administration next year. GC Biopharma received FDA approval for its domestically developed intravenous immunoglobulin Alyglo in 2023 and surpassed $100 million in exports in 2025. Demand for subcutaneous formulations — which offer greater patient convenience — has been rising in the US immunoglobulin market, yet only three 20% high-concentration subcutaneous products are currently available there. GC Biopharma plans to diversify its portfolio through this investment and capture a larger share of the US market, valued at around 20 trillion won. With this latest decision, the National Growth Fund's direct biotech portfolio now spans biosimilar and antibody-drug conjugate (ADC) contract development and manufacturing (CDMO), premium vaccine development, ADC innovative drug research and development, and blood product infrastructure. The fund made its first biotech commitment on April 30, approving an 85 billion won long-term, low-interest loan — 65 billion won from the Advanced Strategic Industry Fund and 20 billion won from Korea Development Bank — for Btigen, a biosimilar CDMO. The financing supports expansion of drug substance and drug product manufacturing at Btigen's factory in Songdo, Incheon, in preparation for increased US supply of its ustekinumab biosimilar Imuldosa. On May 28, the committee approved a 300 billion won low-interest loan for SK Bioscience — 250 billion won from the Advanced Strategic Industry Fund and 50 billion won from Korea Development Bank — to fund global Phase 3 clinical research and development for a 21-valent pneumococcal vaccine being co-developed with France's Sanofi, as well as expansion of SK Bioscience's vaccine factory in Andong, North Gyeongsang Province. On June 25, the committee approved the fund's first direct equity investment in a listed company in the biotech sector, committing 250 billion won of a 500 billion won capital raise by ADC drug developer LigaChem Biosciences through a third-party allotment and convertible bonds. LigaChem Biosciences said the proceeds would allow it to conduct late-stage clinical trials in-house for its highest-priority pipeline assets while maintaining its existing licensing-out strategy. On Aug. 27, the committee approved a 20 billion won low-interest loan for Kyongbo Pharmaceutical to build dedicated ADC CDMO facilities. Including Thursday's approval of 170 billion won for GC Biopharma, the total directly approved by the investment review committee for individual biotech companies now stands at 825 billion won, surpassing the 800 billion won mark. That figure includes 70 billion won in Korea Development Bank matching funds tied to loan commitments; stripping those out, the pure Advanced Strategic Industry Fund component amounts to approximately 755 billion won (assuming Kyongbo Pharmaceutical's 20 billion won is funded entirely from the Advanced Strategic Industry Fund). Alteogen represents a separate case of indirect investment through a delegated fund manager. In October, Alteogen raised a total of 200 billion won through a project fund formed by Skylake, a large-league general partner, which matched contributions from the National Growth Fund. Unlike the direct support portfolio — where the government's review committee identifies individual companies and decides on loans or equity investments — this was an indirect investment executed at the fund manager's discretion. The National Growth Fund is drawing recognition as a national strategic anchor that goes beyond simple financial reinforcement to support the build-out of global commercialization facilities and the advancement of late-stage clinical programs — a form of supply tailored to the biotech industry's need for large capital outlays and long development timelines, some analysts say. GC Biopharma, the latest recipient, had already secured proceeds from the sale of its stake in Curevo and an upfront payment from a licensing deal for its Fabry disease treatment. The low-interest loan will allow the company to supplement those resources as it builds production capacity and funds clinical trials for the US market. "Being selected as a National Growth Fund recipient is recognition of our global business capabilities," GC Biopharma Chief Executive Heo Eun-cheol said. "We will complete our immunoglobulin portfolio — covering both intravenous and subcutaneous administration — by adding the 20% SCIG to our existing Alyglo franchise."
Nov. 4, 2026
-
Celltrion's quadruple-action obesity drug outperforms triple agonist in animal tests
CT-G32/SCO-940 targets GLP-1, GIP, glucagon and amylin simultaneously — a world first Candidate shows greater weight loss than retatrutide at equal doses, with better lean mass preservation Primate PK data support once-weekly dosing; Phase 1 IND filing with FDA planned for February 2027 Celltrion has publicly disclosed for the first time preclinical results for CT-G32/SCO-940, the world's first obesity drug candidate designed to simultaneously target four hormonal pathways in a single molecule. Celltrion said Wednesday it jointly presented preclinical data on CT-G32/SCO-940 — a pipeline asset co-developed with Japan's Scohia Pharma — at TIDES Europe, a global specialty conference held in Amsterdam, the Netherlands, from Tuesday through Thursday (local time). The presentation covered receptor-specific cellular activity assessments as well as key pharmacological findings from a diet-induced obese rat model, including body weight, body composition and blood insulin levels. CT-G32/SCO-940 is a next-generation quadruple agonist that simultaneously targets four hormonal pathways: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon and amylin. Among all obesity drug candidates disclosed globally to date, CT-G32/SCO-940 is the first to integrate all four pathways into a single molecule. According to the preclinical results presented at the conference, CT-G32/SCO-940 produced greater weight loss than Eli Lilly's triple agonist retatrutide when administered at the same dose. Particularly notable was the relatively smaller reduction in lean mass — including muscle and bone — compared with the reference drug during weight loss, demonstrating the potential to significantly improve the balance between weight reduction and body composition preservation. The candidate also lowered elevated blood insulin levels commonly associated with obesity, pointing to potential for expanding its indications into metabolic disease treatment beyond obesity alone. Primate pharmacokinetic evaluations showed that sustained drug exposure was maintained over time. Celltrion said the findings support the feasibility of developing a once-weekly subcutaneous formulation that could improve patient adherence. Building on these preclinical results, Celltrion plans to submit an investigational new drug application to the US Food and Drug Administration for CT-G32/SCO-940 in February 2027. If the regulatory review proceeds without delay, the company aims to dose the first patient in a global Phase 1 trial in the second quarter of that year. Celltrion intends to develop CT-G32/SCO-940 as a first-in-class drug addressing unmet medical needs long cited as limitations of existing GLP-1-based therapies — namely, variability in individual efficacy and muscle loss during weight reduction. Leveraging four complementary mechanisms of action, the company plans to position the candidate as a next-generation core pipeline asset in obesity and metabolic disease by simultaneously achieving weight loss, body composition improvement and energy metabolism regulation. Beyond obesity treatment, Celltrion is steadily expanding its new drug portfolio to include antibody-drug conjugates currently in Phase 1 trials, as well as multi-specific antibody-based anticancer drugs and autoimmune disease treatments. The company's strategy is to apply capabilities accumulated through its biosimilar business — including large-scale global clinical development, mass production, regulatory approval and direct commercialization — across the full drug development cycle to diversify its medium- and long-term growth drivers. "CT-G32/SCO-940 is a core pipeline asset whose preclinical data have confirmed differentiation potential beyond existing dual and triple agonists, as the world's first quadruple-action combination targeting GLP-1, GIP, glucagon and amylin simultaneously," a Celltrion official said. "We will proceed with global clinical entry without delay and develop it into a next-generation obesity treatment that addresses not only weight loss but also body composition and metabolic improvement." TIDES Europe, where the results were unveiled, is a leading global specialty conference for sharing research and development achievements and the latest industry trends in next-generation biotherapeutics, including peptides and oligonucleotides. This year's event drew more than 100 global companies and featured 115 academic and industry experts as speakers.
Nov. 4, 2026
- 1Malaysia's BE International brings 1,500-strong incentive tour to Korea, bypassing Turkey
- 2AI singer tops Melon chart for first time with 'Did You Become the Adult You Dreamed Of?'
- 3Jensen Huang's daughter took the photo of him embracing his alleged mistress
- 4Man beat live-in girlfriend 514 times over 3 hours, killing her; forensic expert says footage was too disturbing to watch
- 5Crosswalk at Cheonggyecheon 6-ga intersection opens after 20 years of resident demands
- 6'A concert is a ritual for the soul': Currentzis makes long-awaited Korea debut after six years
-
WORLD
US warns of punishment for anyone enabling Iran's Strait of Hormuz toll scheme
-
INDUSTRY
Toyota union puts productivity first; Hyundai Motor union demands bigger share of profits
-
FINANCE
National Growth Fund to invest $531M in FuriosaAI, which rebuffed Meta's $800M takeover bid
-
INDUSTRY
Korea Shipowners' Association holds amateur baduk tournament for Maritime Day
